Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumours

Investigational New Drugs
Lot A DevrieseJan H M Schellens

Abstract

To quantify the effect of food on the systemic exposure of lapatinib at steady state when administered 1 h before and after meals, and to observe the safety and tolerability of lapatinib under these conditions in patients with advanced solid tumours. This was a three-treatment, randomised, three-sequence cross-over study. Lapatinib was administered 1 h after a low- [B] or a high-fat [C] meal and systemic exposure was compared with that obtained following administration 1 h before a low-fat meal [A]. In total, 25 patients were included, of whom 12 were evaluable for the pharmacokinetic analysis. Both low-fat and high-fat meals affected lapatinib exposure. Lapatinib AUC0-24 increased following lapatinib administration 1 h after a low-fat meal by 1.80-fold (90 % CI: 1.37-2.37) and after a high-fat meal by 2.61-fold (90 % CI: 1.98-3.43). Lapatinib Cmax increased following lapatinib administration 1 h after a low-fat meal by 1.90-fold (90 % CI: 1.49-2.43) and after a high-fat meal by 2.66-fold (90 % CI: 2.08-3.41). The most commonly occurring treatment-related toxicity was diarrhoea (8/25, 32 % CTCAE grade 1 and 2/25, 8 % grade 2) and one treatment-related grade ≥ 3 event occurred (fatigue grade 3, 4 %). Both low-fat and high-fat fo...Continue Reading

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F ThiebautM C Willingham
Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Jul 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M D DeMario, M J Ratain
Feb 3, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neil L SpectorSarah Bacus
Dec 29, 2006·The New England Journal of Medicine·Charles E GeyerDavid Cameron
Aug 4, 2007·The Oncologist·Beverly Moy, Paul E Goss
Sep 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul M HarariJames A Bonner
Jan 22, 2008·Breast Cancer Research and Treatment·John P CrownSteve Chan
May 7, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry L GomezGeorge W Sledge
Feb 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin M KochLionel D Lewis
Apr 18, 2009·British Journal of Clinical Pharmacology·Deborah A SmithAndrew Beelen
Sep 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen JohnstonMark Pegram
Oct 15, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Howard A BurrisGeorge Wilding
Jan 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Colin F SpraggsLon R Cardon
Mar 19, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S IqbalC D Blanke

❮ Previous
Next ❯

Citations

Mar 21, 2016·Drug Discovery Today·Annelieke E C A B WillemsenNielka P van Erp
Mar 31, 2015·Cancer Treatment Reviews·Maikel HerbrinkJos H Beijnen
Sep 24, 2014·Drug Discovery Today·Djoeke de WitNielka P van Erp
Mar 29, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Russell Z SzmulewitzMark J Ratain
Jan 19, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Guo YuHong-Hao Zhou
Mar 5, 2020·Therapeutic Advances in Medical Oncology·Fausto Meriggi, Alberto Zaniboni
Dec 13, 2019·Journal of Pharmaceutical Health Care and Sciences·Fukiko OmachiFumio Itagaki
Jan 11, 2017·Clinical Pharmacology and Therapeutics·S Parsad, M J Ratain
Mar 31, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kari B WisinskiGlenn Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.